Ayhan Okçuoǧlu Çavdar’s research while affiliated with Ankara University and other places

Adriamycin1 was used on 10 children with acute leukemia and malignant tumors (7 acute leukemia and 3 solid tumors). The malignant tumors were rhabdomyosarcoma and neuroblastoma. The type of leukemia was ALL in 6 cases and AML in one. None of these 10 patients had ever received adriamycin; 4 of the 7 children with acute leukemia had previously been treated with other chemo therapeutic agents and 3 were new cases. Ages ranged from 1.5-12 years and there were 7 boys and 3 girls in the group.

Acute myelomonocytic leukæmia (A.M.M.L.) associated with unusual ocular manifestations in Turkish children is reported. This type of leukæmia was found to account for 40% of all acute leukæmia in childhood. A high incidence of A.M.M.L. with orbital tumours has been reported from Africa.